How Fast? UltraFast®

The SuperSonic® MACH® ultrasound platform is the ONLY diagnostic cart-system with UltraFast® technology, made possible through planewave Imaging.

How Fast? UltraFast®

Explore SuperSonic Imagine®

Who we are?

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine® (SSI) is a world leader in diagnostic medical ultrasound technology.

View more
  • 2005Year established
  • 80+Countries
  • 900 +Property titles
  • 1000+Scientific Publications

Leading the Future

Innovative Approaches

Leading the Future of Ultrasound Technology

Gaming Computing Power

Gaming Computing Power

Exclusive SonicPad™ Technology

Exclusive SonicPad™ Technology

An interface you've already mastered. 25 programmable gestures right at your fingertips.

Unique UltraFast® Technology

Unique UltraFast® Technology

SuperSonic Imagine® has the only diagnostic cart-system with UltraFast® that is 400x faster than conventional imaging.

Pioneers in Real Time ShearWave® Elastography

Pioneers in Real Time ShearWave® Elastography

Patented Real-Time ShearWave® Elastography for all applications on every transducer.

State-Of-The-Art

State-Of-The-Art

We are dedicated to continuous development in premium imaging for diagnostic medical ultrasound, Expanding the frontiers of medical imaging.

Innovation

Innovation

Innovative and advanced imaging modes, protected by IP assets including registered trade secrets contribute to our groundbreaking advancements.

What clinicians say

  • “Very subtle findings that we may find on [this] ultrasound unit, we just don't find on others. Particularly for entities of the breasts that are more inconspicuous or elusive, I have found the SuperSonic® MACH® unit really can be superlative in cancer detection.”

    Dr. Amy PatelMO, Kansas City, Liberty Hospital
  • "The quality, detail, and accuracy of the images we obtain with the SuperSonic® MACH® unit allow us to be very confident with our assessment. Patients are able to sense, and it is so important given our brief interactions with patients during which we need to secure their trust and confidence."

    Dr. Susan ErvineHolland, MI, Holland Hospital
  • "I am able to interact with the patient more because I am not fiddling with knobs and buttons. I am able to focus on the screen and visualizing the finding."

    Dr Smith FoleyAR, Little Rock, CARTI Breast Center
  • "This technology gives us the opportunity to sort which patients we’re able to safely follow versus those who need to get a biopsy. It’s important to me that we’re able to prioritize those patients who truly need biopsies and not delay diagnosis because we’re doing unnecessary benign biopsies."

    Dr. SchillingFL, Boca Raton, Baptist Health